Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 5.29 HKD -2.58%
Market Cap: 4.3B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

Lowest
Price Target
8.94 HKD
69% Upside
Average
Price Target
10.12 HKD
91% Upside
Highest
Price Target
12.52 HKD
137% Upside
Ocumension Therapeutics Competitors:
Price Targets
4886
ASKA Pharmaceutical Holdings Co Ltd
19% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
16% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
21% Upside
SUPRIYA
Supriya Lifescience Ltd
13% Downside
PER
Percheron Therapeutics Ltd
170% Upside
PPLPHARMA
Piramal Pharma Ltd
0% Upside

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

For the last 4 years the compound annual growth rate for Ocumension Therapeutics's revenue is 500%. The projected CAGR for the next 3 years is 81%.

500%
Past Growth
81%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ocumension Therapeutics's stock price target?
Price Target
10.12 HKD

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

What is Ocumension Therapeutics's Revenue forecast?
Projected CAGR
81%

For the last 4 years the compound annual growth rate for Ocumension Therapeutics's revenue is 500%. The projected CAGR for the next 3 years is 81%.

Back to Top